Susan Dina Ghiassian
Susan Dina Ghiassian
Scipher Medicine
Verifierad e-postadress på sciphermedicine.com
Titel
Citeras av
Citeras av
År
A proteome-scale map of the human interactome network
T Rolland, M Taşan, B Charloteaux, SJ Pevzner, Q Zhong, N Sahni, S Yi, ...
Cell 159 (5), 1212-1226, 2014
10252014
Uncovering disease-disease relationships through the incomplete interactome
J Menche, A Sharma, M Kitsak, SD Ghiassian, M Vidal, J Loscalzo, ...
Science 347 (6224), 2015
8762015
A DIseAse MOdule Detection (DIAMOnD) algorithm derived from a systematic analysis of connectivity patterns of disease proteins in the human interactome
SD Ghiassian, J Menche, AL Barabási
PLoS Comput Biol 11 (4), e1004120, 2015
2222015
A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma
A Sharma, J Menche, CC Huang, T Ort, X Zhou, M Kitsak, N Sahni, ...
Human molecular genetics 24 (11), 3005-3020, 2015
1382015
Tissue specificity of human disease module
M Kitsak, A Sharma, J Menche, E Guney, SD Ghiassian, J Loscalzo, ...
Scientific reports 6 (1), 1-12, 2016
712016
Network medicine framework for identifying drug repurposing opportunities for COVID-19
DM Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, H Sanchez, ...
ArXiv, 2020
602020
Endophenotype network models: common core of complex diseases
SD Ghiassian, J Menche, DI Chasman, F Giulianini, R Wang, P Ricchiuto, ...
Scientific reports 6 (1), 1-13, 2016
552016
Clinical validation of a blood-based predictive test for stratification of response to tumor necrosis factor inhibitor therapies in rheumatoid arthritis patients
T Mellors, JB Withers, A Ameli, A Jones, M Wang, L Zhang, HN Sanchez, ...
Network and Systems Medicine 3 (1), 91-104, 2020
42020
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
D Morselli Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, ...
arXiv e-prints, arXiv: 2004.07229, 2020
12020
Network medicine: a network-based approach to human diseases.
SD Ghiassian
12015
A systems-based method to repurpose marketed therapeutics for antiviral use: a SARS-CoV-2 case study
M Wang, JB Withers, P Ricchiuto, I Voitalov, M McAnally, HN Sanchez, ...
Life science alliance 4 (5), 2021
2021
Methods and systems for predicting response to anti-tnf therapies
KJ Johnson, SD Ghiassian
US Patent App. 16/394,046, 2019
2019
System and Methods for Disease Module Detection
S Ghiassian, J Menche, A Sharma, A Barabasi
US Patent App. 15/913,826, 2019
2019
PRISM-RA: A Personalized Medicine Test That Accurately Predicts Rheumatoid Arthritis Patients Who Will Not Respond Adequately to Tumor Necrosis Factor Inhibitors
K Johnson
2018 ACR/ARHP Annual Meeting, 2018
2018
System and Methods for Disease Module Detection
S Ghiassian, J Menche, A Sharma, A Barabasi
US Patent App. 15/023,582, 2016
2016
Network topological analysis reveals the functional cohesiveness for the newly discovered links by Yeast 2 Hybrid approach
S Ghiassian, S Pevzner, T Rolland, M Tassan, AL Barabasi, M Vidal, ...
APS March Meeting Abstracts 2014, L15. 010, 2014
2014
A Network Approach to Rare Disease Modeling
S Ghiassian, S Rabello, A Sharma, O Wiest, AL Barabasi
APS March Meeting Abstracts 2011, Z14. 008, 2011
2011
PMCID: PMC2323270.
I Lemmens, C Fontanillo, R Mosca, A Kamburov, SD Ghiassian, X Yang, ...
Biophys Res Commun 361 (4), 928-33, 2007
2007
A network-based method to repurpose marketed therapeutics for antiviral use: A SARS-CoV-2 case study
S Ghiassian, M Wang, J Withers, P Ricchiuto, I Voitalov, M McAnally, ...
Supplementary Information: Tissue Specificity of Human Disease Module
M Kitsak, A Sharma, J Menche, E Guney, SD Ghiassian, J Loscalzo, ...
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20